Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study

被引：0
|
作者：
Rasmussen, Daniel [1 ]
Bodtger, Uffe [1 ]
Lamberts, Morten [2 ]
Lange, Peter [3 ]
Jensen, Magnus [2 ]
机构：
[1] Naestved Hosp, Resp Res Unit Zealand, Dept Resp Med, Naestved, Denmark
[2] Herlev & Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Copenhagen, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA4439
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4439
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Benefit of Immediate Beta-Blocker Therapy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction
    Hirschl, Michael M.
    Wollmann, Christian G.
    Erhart, Friedrich
    Brunner, Walter
    Pfeffel, Franz
    Gattermeier, Martin
    Steger, Friedrich
    Mayr, Harald
    CRITICAL CARE MEDICINE, 2013, 41 (06) : 1396 - 1404
  • [32] Beta-Blocker Use in US Nursing Home Residents After Myocardial Infarction: A National Study
    Zullo, Andrew R.
    Lee, Yoojin
    Daiello, Lori A.
    Mor, Vincent
    Boscardin, W. John
    Dore, David D.
    Miao, Yinghui
    Fung, Kathy Z.
    Komaiko, Kiya D. R.
    Steinman, Michael A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (04) : 754 - 762
  • [33] Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study
    Steffen Christensen
    Martin Berg Johansen
    Else Tønnesen
    Anders Larsson
    Lars Pedersen
    Stanley Lemeshow
    Henrik Toft Sørensen
    Critical Care, 15
  • [34] Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study
    Christensen, Steffen
    Johansen, Martin Berg
    Tonnesen, Else
    Larsson, Anders
    Pedersen, Lars
    Lemeshow, Stanley
    Sorensen, Henrik Toft
    CRITICAL CARE, 2011, 15 (02):
  • [35] Beta blocker prescribing differences in patients with and without diabetes following a first myocardial infarction
    Younis, N
    Burnham, P
    Patwala, A
    Weston, PJ
    Vora, JP
    DIABETIC MEDICINE, 2001, 18 (02) : 159 - 161
  • [36] Beta blocker use and mortality in hospital survivors of acute myocardial infarction without heart failure
    Dondo, T. B.
    Hall, M.
    West, R.
    Jernberg, T.
    Lindahl, B.
    Bueno, H.
    Deanfield, J. E.
    Hemingway, H.
    Timmis, A. D.
    Gale, C. P.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1253 - 1253
  • [37] Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study
    Christel, Bruggmann
    Stephane, Fournier
    Alice, Panchaud
    Olivier, Muller
    Farshid, Sadeghipour
    Pierre, Voirol
    SWISS MEDICAL WEEKLY, 2020, 150
  • [38] Intravenous Beta-blocker therapy for ST-Segment Elevation Myocardial Infarction could be associated with higher short-term mortality: a Swedish Nationwide Observational Study
    Mohammad, M.
    Andell, P.
    Koul, S.
    Desta, L.
    Jernberg, T.
    Omerovic, E.
    Spaak, J.
    Frobert, O.
    Jensen, J.
    Hofman-Bang, C.
    Persson, H.
    Erlinge, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 176 - 176
  • [39] Use of sulphonylureas and mortality after myocardial infarction in diabetic patients: a Danish nationwide population-based study
    Thisted, H.
    Jacobsen, J.
    Thomsen, R. W.
    Johnsen, S. P.
    Rungby, J.
    DIABETOLOGIA, 2006, 49 : 57 - 58
  • [40] Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study
    Ahl, Rebecka
    Matthiessen, Peter
    Sjolin, Gabriel
    Cao, Yang
    Wallin, Goran
    Ljungqvist, Olle
    Mohseni, Shahin
    BMJ OPEN, 2020, 10 (07):
12345